Excoffon Katherine J D A, Koerber James T, Dickey David D, Murtha Matthew, Keshavjee Shaf, Kaspar Brian K, Zabner Joseph, Schaffer David V
Department of Internal Medicine, University of Iowa, 440 EMRB, Iowa City, IA 52241, USA.
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3865-70. doi: 10.1073/pnas.0813365106. Epub 2009 Feb 23.
Respiratory viruses evolve to maintain infectivity levels that permit spread yet prevent host and virus extinction, resulting in surprisingly low infection rates. Respiratory viruses harnessed as gene therapy vectors have illustrated this limitation. We used directed evolution in an organotypic human airway model to generate a highly infectious adeno-associated virus. This virus mediated gene transfer more than 100-fold better than parental strains and corrected the cystic fibrosis epithelial Cl(-) transport defect. Thus, under appropriate selective pressures, viruses can evolve to be more infectious than observed in nature, a finding that holds significant implications for designing vectors for gene therapy and for understanding emerging pathogens.
呼吸道病毒不断进化以维持感染水平,既要保证病毒得以传播,又要防止宿主和病毒灭绝,这导致感染率出奇地低。用作基因治疗载体的呼吸道病毒已证实了这一局限性。我们在人呼吸道器官型模型中运用定向进化技术,生成了一种高传染性的腺相关病毒。这种病毒介导的基因转移效果比亲本菌株高出100多倍,并纠正了囊性纤维化上皮细胞的氯离子转运缺陷。因此,在适当的选择压力下,病毒能够进化得比自然界中观察到的更具传染性,这一发现对于设计基因治疗载体和理解新出现的病原体具有重要意义。